Alternative medications may one day be used to treat new incidences of type 2 diabetes while also reducing the dependence on traditional ones. With more clinical investigations underway, the development of novel drugs aims to fill a needed gap in patient care.
Shannon Wallet, PhD, a researcher in the UF Health Department of Periodontology, focuses on the link between periodontal disease and diabetes as highlighted in a recent WCJB TV20 news segment.
See the latest online issue of UF Explore magazine for an in-depth profile of Pat Concannon, PhD, director of the UF Genetics Institute. Concannon's research focuses on autoimmune diseases, particularly type 1 diabetes; pages 22-27.
Fellow UF Gator Alum Jonathan Wald proves that diabetes does not have to "run" your life. In spite of having no insulin production for many years, Jonathan has been able to maintain excellent control of his diabetes, and recently took part in the 21st Annual Walt Disney World Marathon. Check out his success story!
The American Diabetes Association has issued its 'Standards of Medical Care in Diabetes' for 2014, which includes references to the research work of several UF Health diabetes research faculty. The standards emphasize an individualized approach to managing diabetes and discusses current criteria for diabetes diagnosis.
Are you 50 years or older and have established Type 2 diabetes and heart disease -- or risk factors for heart disease or chronic kidney disease? UF Health physicians are seeking participants for a new trial involving a once-daily new-generation insulin product.
A recent editorial piece published in the October edition of Nature Magazine cites the research work of one UF Health physician as growing concern for consumption of fructose, and the implications for development of liver disorders, cardiovascular disease, and type 2 diabetes.
Four distinguished UF Health diabetes experts will be heading 'Down Under' to Australia during the first week of December to highlight Type 1 diabetes (T1D) research work at the 13th International Congress of the Immunology Diabetes Society (IDS) in Lorne, Australia.
UF Health diabetes researchers and patients will take part in a pilot study to determine whether metformin can improve blood sugar in patients with type 1 diabetes. JDRF and the Leona M. and Harry B. Helmsley Charitable Trust are funding the study and the DCE is one of only two Florida research centers participating.
World Diabetes Day, on November 14, is about mobilizing the global diabetes community to produce a powerful voice for diabetes awareness. Together, we can mobilize the campaign for diabetes awareness, and build on the effort to promote diabetes care, prevention and finding a cure worldwide.
